Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

267 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Randomized phase II trials: a long-term investment with promising returns.
Sharma MR, Stadler WM, Ratain MJ. Sharma MR, et al. J Natl Cancer Inst. 2011 Jul 20;103(14):1093-100. doi: 10.1093/jnci/djr218. Epub 2011 Jun 27. J Natl Cancer Inst. 2011. PMID: 21709274 Free PMC article. Review.
Homozygous deletions within chromosomal bands 9p21-22 in bladder cancer.
Stadler WM, Sherman J, Bohlander SK, Roulston D, Dreyling M, Rukstalis D, Olopade OI. Stadler WM, et al. Cancer Res. 1994 Apr 15;54(8):2060-3. Cancer Res. 1994. PMID: 7513608
Low-dose interleukin-2 in the treatment of metastatic renal-cell carcinoma.
Stadler WM, Vogelzang NJ. Stadler WM, et al. Semin Oncol. 1995 Feb;22(1):67-73. Semin Oncol. 1995. PMID: 7855621 Review. No abstract available.
Metastatic bladder cancer: advances in treatment.
Stadler WM, Kuzel TM, Raghavan D, Levine E, Vogelzang NJ, Roth B, Dorr FA. Stadler WM, et al. Eur J Cancer. 1997 Jan;33 Suppl 1:S23-6. doi: 10.1016/s0959-8049(96)00337-1. Eur J Cancer. 1997. PMID: 9166096 Review.
Granulocyte-macrophage--colony stimulating factor in metastatic renal cell carcinoma: a phase II trial.
Rini BI, Stadler WM, Spielberger RT, Ratain MJ, Vogelzang NJ. Rini BI, et al. Cancer. 1998 Apr 1;82(7):1352-8. doi: 10.1002/(sici)1097-0142(19980401)82:7<1352::aid-cncr19>3.0.co;2-5. Cancer. 1998. PMID: 9529028 Clinical Trial.
Study of cohort-specific consent and patient control in phase I cancer trials.
Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler M. Daugherty CK, et al. J Clin Oncol. 1998 Jul;16(7):2305-12. doi: 10.1200/JCO.1998.16.7.2305. J Clin Oncol. 1998. PMID: 9667244 Clinical Trial.
Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases.
Chekmareva MA, Kadkhodaian MM, Hollowell CM, Kim H, Yoshida BA, Luu HH, Stadler WM, Rinker-Schaeffer CW. Chekmareva MA, et al. Cancer Res. 1998 Nov 1;58(21):4963-9. Cancer Res. 1998. PMID: 9810006
Mitogen-activated protein kinase kinase 4/stress-activated protein/Erk kinase 1 (MKK4/SEK1), a prostate cancer metastasis suppressor gene encoded by human chromosome 17.
Yoshida BA, Dubauskas Z, Chekmareva MA, Christiano TR, Stadler WM, Rinker-Schaeffer CW. Yoshida BA, et al. Cancer Res. 1999 Nov 1;59(21):5483-7. Cancer Res. 1999. PMID: 10554023
Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: a University of Chicago Phase II Consortium study.
Stadler WM, Vogelzang NJ, Amato R, Sosman J, Taber D, Liebowitz D, Vokes EE. Stadler WM, et al. J Clin Oncol. 2000 Jan;18(2):371-5. doi: 10.1200/JCO.2000.18.2.371. J Clin Oncol. 2000. PMID: 10637252 Clinical Trial.
267 results
Jump to page
Feedback